Notice of Special Interest (NOSI): Administrative Supplements to Support Vanguard Study for CSRN Investigators
The National Cancer Institute (NCI) is offering additional funding for existing Cancer Screening Research Network (CSRN) awardees to support the Vanguard Study.
Source
Dates
Keywords
Supporting Links
Documents
Similar Opportunities
-
Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)
National Institutes of Health ▸ National Cancer Institute
-
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)
National Institutes of Health ▸ National Cancer Institute
-
NCI Pathway to Independence Award (K99/R00 – Clinical Trial Not Allowed)
National Institutes of Health ▸ National Cancer Institute
-
NIDCD Research Career Enhancement Award for Established Investigators (K18 Clinical Trial Required)
National Institutes of Health ▸ National Institute on Deafness and Other Communication Disorders
-
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
National Institutes of Health ▸ National Cancer Institute
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers